What is the treatment for vitamin D deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Vitamin D deficiency is typically treated with vitamin D supplements, usually in the form of vitamin D3 (cholecalciferol), with a common treatment regimen being 50,000 IU of vitamin D3 taken once weekly for 8 weeks, followed by a maintenance dose of 1,000-2,000 IU daily. The treatment approach may vary depending on the severity of the deficiency, with severe deficiency (levels below 10 ng/mL) potentially requiring a longer duration of high-dose treatment before switching to maintenance.

Key Considerations

  • The goal of treatment is to achieve a 25(OH)D level of >32 ng/mL, although some experts recommend levels in the 40–50 ng/mL range 1.
  • Vitamin D supplements should be taken with food containing some fat to improve absorption, as vitamin D is fat-soluble.
  • In addition to supplements, increasing sun exposure (15-30 minutes several times weekly) and consuming vitamin D-rich foods like fatty fish, egg yolks, and fortified dairy products can help maintain levels.
  • Follow-up blood tests are recommended after 3-6 months of treatment to ensure levels have normalized and to adjust dosing if needed.

Treatment Regimens

  • For moderate deficiency (vitamin D levels between 10-20 ng/mL), a common treatment regimen is 50,000 IU of vitamin D3 taken once weekly for 8 weeks, followed by a maintenance dose of 1,000-2,000 IU daily.
  • For severe deficiency (levels below 10 ng/mL), the same weekly dose may be continued for 12 weeks before switching to maintenance.
  • Daily dosing of vitamin D for 25(OH)D concentrations >15 ng/mL is generally preferred, while high-dose loading can be considered for those with lower 25(OH)D concentrations or secondary hyperparathyroidism 1.

Safety and Efficacy

  • Treatment with oral vitamin D does not seem to be associated with serious harms, although toxicity can occur at very high levels (>500 nmol/L [>200 ng/mL]) 1.
  • The efficacy of vitamin D supplements in preventing fractures and other outcomes is still a topic of ongoing research, but correcting vitamin D deficiency is essential for maintaining bone health and preventing related complications.

From the FDA Drug Label

Health Claims DIETARY SUPPLEMENT Vitamin D3 50,000 IU is essential for absorption of calcium and necessary for healthy bones and a healthy immune system. The treatment for vitamin D deficiency is supplementation with Vitamin D, such as Cholecalciferol (Vitamin D3). The specific dosage may vary, but 50,000 IU is mentioned as a relevant amount in the context of vitamin D supplementation 2.

From the Research

Treatment of Vitamin D Deficiency

  • The goal of treatment is to normalize vitamin D levels to relieve symptoms and decrease the risk of fractures, falls, and other adverse health outcomes 3.
  • Treatment may include oral ergocalciferol (vitamin D2) at 50,000 IU per week for eight weeks, followed by maintenance dosages of cholecalciferol (vitamin D3) at 800 to 1,000 IU per day from dietary and supplemental sources 3.
  • Cholecalciferol is the preferred form of vitamin D for exogenous supplementation, as it guarantees an exact dosage in IU and has pharmacokinetic properties that allow for daily or weekly administration 4.
  • A cumulative dose of at least 600,000 IU of vitamin D administered over several weeks may be necessary to replenish vitamin D stores in patients with documented deficiency 5.
  • Single large doses of 300,000-500,000 IU should be avoided, and vitamin D supplementation should not be offered routinely to patient populations without documented deficiency 5.

Comparison of Cholecalciferol and Ergocalciferol

  • Cholecalciferol therapy has been shown to be more effective at raising serum 25(OH)D levels than ergocalciferol therapy in non-dialysis-dependent chronic kidney disease patients 6.
  • However, levels of 25(OH)D declined substantially in both arms following cessation of therapy, suggesting the need for maintenance therapy to sustain levels 6.
  • Cholecalciferol (vitamin D3) is considered a better option than ergocalciferol (vitamin D2) for supplementation in older adults due to its more effective absorption and utilization in the body 7.

Dosage and Administration

  • The American Academy of Pediatrics recommends that infants and children receive at least 400 IU per day from diet and supplements to prevent vitamin D deficiency 3.
  • Evidence shows that vitamin D supplementation of at least 700 to 800 IU per day reduces fracture and fall rates in adults 3.
  • Vitamin D in doses of 800-5000 IU/day can improve musculoskeletal health, such as reducing the rate of fractures and falls in older adults (aged ≥ 65 yrs) 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.